Back - Takaisin

Next - Seuraava

Previous - Edellinen

Print - Tulosta

	Comment to: - Komentti viestiin: Levtr
	I'd like a phonecard, please http://xvedio.in.net/xvidoes/ xvidoes.com A new study has found that the vast majority of rheumatoid arthritis (RA) patients in the US being treated with Amgen’s Enbrel (etanercept) and AbbVie’s Humira (adalimumab) are biologic-naïve and, therefore, taking these drugs as their first-line biologic treatment. , Author: - Kirjoittanut: Anonymous, 05/22/2019,
	Message: - Viesti:
	I'd like a phonecard, please http://xvedio.in.net/xvidoes/ xvidoes.com A new study has found that the vast majority of rheumatoid arthritis (RA) patients in the US being treated with Amgen’s Enbrel (etanercept) and AbbVie’s Humira (adalimumab) are biologic-naïve and, therefore, taking these drugs as their first-line biologic treatment.